Claim Missing Document
Check
Articles

Found 2 Documents
Search

Pengaruh Pemberian Puding Kurma Susu Rendah Lemak Terhadap Penurunan Tekanan Darah Pada Penderita Hipertensi Anisa Dwi Rachmawati; Gurid Pramintarto Eko Mulyo; Yenny Moviana; Yohannes Willihelm Saleky; Jedya Lucas A. Purba
Jurnal Gizi dan Dietetik Vol. 5 No. 1 (2026): Jurnal Gizi dan Dietetik
Publisher : Jurusan Gizi Poltekkes Kemenkes Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.34011/jgd.v5i1.4730

Abstract

Potassium and calcium have the potential to lower hypertension. Food sources of potassium and calcium are found in foods such as dates and low-fat milk, which are often made into pudding. This study aimed to determine the effect of low-fat milk and date pudding on lowering blood pressure in hypertensive patients in the Pasirkaliki Community Health Center (Puskesmas) area in Cimahi. The design used was a quasi-experimental two-group pretest-posttest with control group design. The study subjects were 30 hypertensive patients aged 26–65 years. They were divided into a treatment group, given 240 g of pudding daily, with 120 g each in the morning and evening, and a control group, given DASH diet education once for 7 consecutive days. The sampling technique used purposive sampling. The results showed a decrease in systolic blood pressure in the treatment group, with an average of 132.66 mmHg to 129.6 mmHg, a decrease of 3.06 mmHg, but the decrease was not significant (p=0.104), and an increase in diastolic blood pressure, with an average of 84.6 mmHg to 85.86 mmHg, a decrease of 1.26 mmHg, indicating a non-significant increase (p=0.504). In the control group, there was an increase in systolic blood pressure, with an average of 132.86 mmHg to 135.33 mmHg, a 2.47 mmHg increase, but this increase was not significant (p=0.396), and a decrease in diastolic blood pressure, with an average of 85.66 mmHg to 84.6 mmHg, indicating a non-significant decrease (p=0.575). The results showed no significant difference in the reduction of systolic (p=0.107) and diastolic (p=0.433) blood pressure between the treatment and control groups. It is recommended that longer-term interventions be conducted, taking into account the dosage.
High Energy High Protein Enteral Nutrition from Soybean and Cowpea for Tuberculosis Patients Yuni Prisilia Sihotang; Yenny Moviana; Surmita; Mona Fitria
Jurnal Gizi dan Dietetik Vol. 5 No. 1 (2026): Jurnal Gizi dan Dietetik
Publisher : Jurusan Gizi Poltekkes Kemenkes Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.34011/jgd.v5i1.4737

Abstract

Tuberculosis is a directly transmitted infectious disease caused by Mycobacterium tuberculosis. Patients with tuberculosis (TB) are at risk of experiencing a decline in nutritional status if not supported by an appropriate dietary intake. Nutritional requirements can be met through the administration of enteral nutrition. Enteral Soyvia is a high-energy, high-protein alternative enteral food product formulated from soybeans (Glycine max) and cowpeas (Vigna unguiculata). This study aimed to evaluate the effect of varying formulations of soybean and cowpea flour on the organoleptic properties, total energy, macronutrient content (protein, fat, and carbohydrates), flow rate, and osmolality of the product. An experimental design was employed using three formulations: F1 (40% soybean flour: 60% cowpea flour), F2 (50%:50%), and F3 (60%:40%). Organoleptic properties were assessed through hedonic testing involving 30 semi-trained panelists. The results indicated that the F2 formulation had the most favorable organoleptic characteristics, with an overall acceptance score of 5.57. The Kruskal–Wallis test showed that differences in soybean and cowpea flour ratios significantly affected taste (p = 0.006) and consistency (p = 0.023). Nutritional analysis revealed that all formulations met the energy and carbohydrate requirements for enteral nutrition and qualified as high-protein; however, the fat content did not meet standard enteral nutrition criteria. The flow rate of Enteral Soyvia F1 met the tolerance standards for bolus administration of enteral formulas. However, the osmolality of all formulations exceeded the recommended limits for enteral products. The production cost per serving of Enteral Soyvia was economical, estimated at approximately 36% of the market price of commercial high-energy, high-protein enteral formulas. Further research is recommended to enhance the formulation by incorporating additional ingredients to meet all nutritional standards for enteral food products.